{"id":354061,"date":"2025-11-04T03:11:15","date_gmt":"2025-11-04T03:11:15","guid":{"rendered":"https:\/\/www.europesays.com\/us\/354061\/"},"modified":"2025-11-04T03:11:15","modified_gmt":"2025-11-04T03:11:15","slug":"580k-bottles-of-blood-pressure-medications-recalled-due-to-cancer-causing-chemical-wsoc-tv-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/354061\/","title":{"rendered":"580K bottles of blood pressure medications recalled due to cancer-causing chemical \u2013 WSOC TV"},"content":{"rendered":"<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">More than half a million bottles of a popular blood pressure medication have been recalled because they contain a chemical that could cause cancer. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The <a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=97755\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=97755\">Food and Drug Administration<\/a> issued an alert affecting more than 580,800 bottles of Prazosin Hydrochloride capsules distributed by Teva Pharmaceuticals.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">Three dosages are part of the recall: 1 mg, 2 mg and 5 mg. <\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">Prazosin Hydrochloride is used to treat high blood pressure and in off-label usage, can help treat symptoms of post-traumatic stress disorder, specifically for nightmares and sleep problems, <a href=\"https:\/\/www.usatoday.com\/story\/news\/health\/2025\/10\/29\/blood-pressure-medicine-recalled-prazosin-hydrochloride\/86966059007\/\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"https:\/\/www.usatoday.com\/story\/news\/health\/2025\/10\/29\/blood-pressure-medicine-recalled-prazosin-hydrochloride\/86966059007\/\">USA Today<\/a> reported.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The FDA said the medications have an N-nitroso Prazosin impurity C that is higher than the acceptable levels.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">The following medication lots are being recalled<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\"><b>Prazosin Hydrochloride, 1 mg capsules, recall number D-0104-2026 (181,659 bottles)<\/b><\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC number NDC 0093-4067-01 (100 capsules)<\/p>\n<ul>\n<li>3010544A, Exp Date: 10\/2025<\/li>\n<li>3010545A, Exp Date: 10\/2025<\/li>\n<li>3010567A, Exp Date: 12\/2025<\/li>\n<li>3010590A, Exp Date: 02\/2026<\/li>\n<li>3010601A, Exp Date: 03\/2026<\/li>\n<li>3010602A, Exp Date: 03\/2026<\/li>\n<li>3010603A, Exp Date: 03\/2026<\/li>\n<li>3010652A, Exp Date: 07\/2026<\/li>\n<li>3010670A, Exp Date: 07\/2026<\/li>\n<li>3010671A, Exp Date: 07\/2026<\/li>\n<li>3010678A, Exp Date: 08\/2026<\/li>\n<li>3010700A, Exp Date: 08\/2026<\/li>\n<li>3010701A, Exp Date: 08\/2026 <\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC 0093-4067-10 (1,000 capsules)<\/p>\n<ul>\n<li>3010440A, Exp Date: 12\/2025<\/li>\n<li>3010672A, Exp Date: 07\/2026<\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\"><b>Prazosin Hydrochloride, 2 mg capsules, recall number D-0105-2026 (<\/b><b>291,512<\/b><b> bottles)<\/b><\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC 0093-4068-01 (100 capsules)<\/p>\n<ul>\n<li>3010398A, Exp Date: 12\/2025<\/li>\n<li>3010399A, Exp Date: 12\/2025<\/li>\n<li>3010400A, Exp Date: 12\/2025<\/li>\n<li>3010401A, Exp Date: 12\/2025<\/li>\n<li>3010353A, Exp Date: 12\/2025<\/li>\n<li>3010439A, Exp Date: 01\/2026<\/li>\n<li>3010388A, Exp Date: 01\/2026<\/li>\n<li>3010526A, Exp Date: 03\/2026<\/li>\n<li>3010527A, Exp Date: 03\/2026<\/li>\n<li>3010591A, Exp Date: 07\/2026<\/li>\n<li>3010343A, Exp Date: 10\/2025<\/li>\n<li>3010352A, Exp Date: 11\/2025<\/li>\n<li>3010468A, Exp Date: 02\/2026<\/li>\n<li>3010469A, Exp Date: 02\/2026<\/li>\n<li>3010461A, Exp Date: 02\/2026<\/li>\n<li>3010629A, Exp Date: 09\/2026<\/li>\n<li>3010653A, Exp Date: 01\/2027<\/li>\n<li>3010654A, Exp Date: 02\/2027<\/li>\n<li>3010679A, Exp Date: 02\/2027<\/li>\n<li>3010702A, Exp Date: 02\/2027<\/li>\n<li>3010547A, Exp Date: 04\/2026<\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC 0093-4068-10 (1,000 capsules)<\/p>\n<ul>\n<li>3010402A Exp Date: 02\/2028<\/li>\n<li>3010593A, Exp Date: 07\/2026<\/li>\n<li>3010610A, Exp Date: 09\/2026<\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\"><b>Prazosin Hydrochloride, 5 mg capsules, recall number D-0106-2026 (107,673 bottles)<\/b><\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC 0093-4069-01 (100 capsules)<\/p>\n<ul>\n<li>3010403A, Exp Date: 02\/2026<\/li>\n<li>3010385A, Exp Date: 02\/2026<\/li>\n<li>3010404A, Exp Date: 02\/2026<\/li>\n<li>3010405A, Exp Date: 03\/2026<\/li>\n<li>3010510A, Exp Date: 03\/2026<\/li>\n<li>3010528A, Exp Date: 03\/2026<\/li>\n<li>3010354A, Exp Date: 03\/2026<\/li>\n<li>3010592A, Exp Date: 08\/2026<\/li>\n<li>3010605A, Exp Date: 08\/2026<\/li>\n<li>3010611A, Exp Date: 08\/2026<\/li>\n<li>3010612A, Exp Date: 08\/2026<\/li>\n<li>3010655A, Exp Date: 02\/2027<\/li>\n<li>3010703A, Exp Date: 02\/2027<\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC 0093-4069-52 (250 capsules)<\/p>\n<ul>\n<li>3010430A, Exp Date: 11\/2025<\/li>\n<li>3010613A, Exp Date: 08\/2026<\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">NDC 0093-4069-05 (500 capsules)<\/p>\n<ul>\n<li>3010406A, Exp Date: 02\/2026<\/li>\n<\/ul>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\"><a href=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=97755\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"https:\/\/www.accessdata.fda.gov\/scripts\/ires\/?Event=97755\">The FDA has classified<\/a> the recall as a <a href=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"https:\/\/www.fda.gov\/safety\/industry-guidance-recalls\/recalls-background-and-definitions\">Class II<\/a>, which is \u201ca situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.\u201d<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph\">No official guidance has been issued on what to do with the recalled medication, but <a href=\"https:\/\/www.goodrx.com\/drugs\/medication-basics\/why-drugs-get-recalled?srsltid=AfmBOorkGBurCUL8BvtQQk6MFsg_ACuKwYzgr6_8YAEwyz228SZAycoY\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"https:\/\/www.goodrx.com\/drugs\/medication-basics\/why-drugs-get-recalled?srsltid=AfmBOorkGBurCUL8BvtQQk6MFsg_ACuKwYzgr6_8YAEwyz228SZAycoY\">GoodRx<\/a> advises people with any recalled medications to check the lot number and contact a pharmacist and prescriber, then throw away the medication, <a href=\"https:\/\/www.usatoday.com\/story\/news\/health\/2025\/10\/29\/blood-pressure-medicine-recalled-prazosin-hydrochloride\/86966059007\/\" target=\"_blank\" rel=\"noreferrer noopener\" title=\"https:\/\/www.usatoday.com\/story\/news\/health\/2025\/10\/29\/blood-pressure-medicine-recalled-prazosin-hydrochloride\/86966059007\/\">USA Today<\/a> reported.<\/p>\n<p class=\"default__StyledText-sc-tl066j-0 jyMHRV body-paragraph body-copyright\">\u00a92025 Cox Media Group<\/p>\n","protected":false},"excerpt":{"rendered":"More than half a million bottles of a popular blood pressure medication have been recalled because they contain&hellip;\n","protected":false},"author":3,"featured_media":343866,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[34],"tags":[169260,151,6434,210,169258,1060,169263,169261,22749,169259,12310,169262,67,132,68],"class_list":{"0":"post-354061","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-medication","8":"tag-blood-pressure-medication","9":"tag-fda","10":"tag-food-and-drug-administration","11":"tag-health","12":"tag-latest-recall","13":"tag-medication","14":"tag-n-nitroso-prazosin-impurity-c","15":"tag-prazosin-hydrochloride-capsules","16":"tag-recall","17":"tag-recall-alert","18":"tag-recalls","19":"tag-teva-pharmaceuticals","20":"tag-united-states","21":"tag-unitedstates","22":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115489242352743275","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/354061","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=354061"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/354061\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/343866"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=354061"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=354061"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=354061"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}